No Detail Found!

Heterologous COVID-19 vaccines intervention effect on reactogenicity

Author(s)
Wajeha Najeeb Pakistan Institute of Medical Sciences, Islamabad, Pakistan
Palvasha Waheed Army Medical College, National University of Medical Sciences, Rawalpindi, Pakistan
Rehana Khadim Army Medical College, Rawalpindi, Pakistan.
Abstract
To determine the change in the occurrence of short-term vaccine reactions on the use of heterologous Covid-19 booster, a single centre short-term study of two months duration was conducted. It was designed as an interventional study with registered clinical trial number # SLCTR/2022/008. It was conducted on medical students and faculty of a National university of medical sciences, Rawalpindi affiliated public sector medical college. A total of 348 individuals were administered with Ad5-nCoV vaccine and 101 with mRNA-1273 vaccine. They all had been previously vaccinated with two doses of BBIBP-CorV. BBIBP-CorV reactogenicity was considered a control group. Vaccine reactions, including pain and redness at the injection site, fever, no observed reactions at all, myalgia, feeling cold, dizziness, paraesthesia in the arm, lightheadedness, had a signifi cant change in their frequencies in comparison to homologous vaccine (BBIBP-CorV) reactogenicity. It was concluded that mixing and matching of COVID-19 vaccines result in an increase in frequency of post-vaccine short-term reactions.
Publication Details
Page(s) 134-137
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 74, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
Adverse effects, COVID-19 Vaccines, Booster immunisation
0

Citations

0

Downloads

63

Views